Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,836 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06516562Recruiting
Heart failure study in Vietnam: following patients' health over time
This study follows people with heart failure in Vietnam to understand their health and treatment over time. It does not test a new drug—just collects information to improve care.
Ho Chi Minh CityAges 18 years+ - NCT06516848Recruiting
High-intensity breathing muscle training for asthma
This study tests whether a high-intensity training program for your breathing muscles can help control severe asthma symptoms. It is for people with non-allergic asthma who are already on treatment.
Istanbul, ÜsküdarAges 18–65 - NCT06517017RecruitingPhase 2
Gentle combination therapy for frail myeloma patients
This study tests a combination of three drugs (isatuximab, dexamethasone, and lenalidomide) given at a slow, gentle pace for people with multiple myeloma who are considered very frail. The goal is to see if this gentler approach works well and is safe for those who may not tolerate stronger treatments.
Salt Lake City, UtahAges 18 years+ - NCT06517069Recruiting
Acupuncture plus medication for pain after gynecologic surgery
This study tests whether adding a type of acupuncture (TEAS) to pain medication can better control pain after laparoscopic gynecologic surgery. It aims to improve recovery and comfort.
Yangzhou, JiangsuAges 18–65 - NCT06517238Recruiting
Digital tool to improve dental care during braces treatment
This trial tests a new digital communication tool that helps your dentist and orthodontist work together better. The goal is to improve how your teeth are cared for while you have braces.
ReimsAges 8–18 - NCT06517511RecruitingPhase 2
Selinexor plus R-CHOP for first-line treatment of TP53-mutated DLBCL
This trial tests adding selinexor to the standard R-CHOP chemotherapy for people with a specific type of diffuse large B-cell lymphoma (DLBCL) that has a TP53 mutation. The goal is to see if this combination works better as the first treatment.
Guangzhou, GuangdongAges 18–80 - NCT06517498Recruiting
Understanding daily life with facioscapulohumeral muscular dystrophy
This study explores how facioscapulohumeral muscular dystrophy (FSHD) affects your daily life, health, and living situation. It does not test a new treatment, but aims to better understand the challenges patients face.
Xi'an, ShaanxiAges Any age - NCT06518434RecruitingPhase 2
Cannabis oil for advanced liver cancer study
This study tests if cannabis oil can help people with advanced liver cancer that cannot be treated with standard therapies. It is a small pilot study to see if the oil is safe and may improve symptoms or quality of life.
GroningenAges 18 years+ - NCT06518694RecruitingPhase 3
Can you stop beta-blockers after heart failure recovery?
This trial tests whether people whose heart function has returned to normal after heart failure can safely stop taking beta-blockers. It aims to see if staying on the medication is still needed or if stopping is just as safe.
Paris, IDFAges 18 years+ - NCT06519136Recruiting
Second level Reiki for pain and quality of life in dialysis
This study tests whether a second level of Reiki (a gentle energy healing practice) can help reduce pain and improve quality of life for people on dialysis. If you already received Reiki level 1 in a previous round of this study, you may be able to join.
ÇorumAges 28–84 - NCT06519266RecruitingPhase 3
Liver treatment with immunotherapy for uveal melanoma that spread to the liver
This trial tests whether adding a liver-directed therapy (PHP) to a combination of two immunotherapy drugs (ipilimumab and nivolumab) works better than the immunotherapy drugs alone for people whose uveal melanoma has spread to the liver.
GothenburgAges 18 years+ - NCT06519292Recruiting
Heart side effects from immunotherapy in cancer patients
This trial looks at whether immunotherapy drugs (checkpoint inhibitors) cause heart problems in people with certain cancers. It will help doctors understand who is at risk and how to monitor for side effects.
Amsterdam, North HollandAges 50 years+ - NCT06519552RecruitingPhase 1
Gene therapy study for adults with MPS type I
This study tests a new gene therapy called JWK008 for adults with MPS type I. The goal is to see if it is safe and can help improve symptoms. You may be able to join if you are 18 or older and have not had serious side effects from enzyme replacement therapy.
Chengdu, SichuanAges 18 years+ - NCT06519435Recruiting
Blood flow check for leg vein blockages with gentle pressure
This study uses a device that gently presses on your calf to check blood flow in leg veins, along with an ultrasound you already had. It may help doctors better understand vein blockages.
Rochester, MinnesotaAges 18 years+ - NCT06519474Recruiting
Elastic chest wrap for COPD breathing and walking
This study tests if wearing an elastic chest wrap during exercise can help people with COPD breathe better and walk farther. You would do breathing and walking tests with and without the wrap to see if it makes a difference.
HsinchuAges 20 years+ - NCT06519526RecruitingPhase 2
Study of two drugs for relapsed peripheral T-cell lymphoma
This study tests two new drugs (SHR-0302 and SHR-2554) for people with a type of lymphoma (peripheral T-cell lymphoma) that has come back or not responded to prior treatment. The goal is to see if the combination can help control the cancer.
ShanghaiAges 18–70 - NCT06519682Recruiting
Immunotherapy for young people with a specific brain tumor
This trial is testing a new immunotherapy (nivolumab) for children, teens, and young adults with a specific type of aggressive brain tumor (glioblastoma that has a DNA repair problem). It aims to see if giving this treatment early, right after surgery, can help the immune system fight the tumor.
Toronto, OntarioAges 1–25 - NCT06519942Recruiting
Muscle and bone health in diabetes with nerve damage
This study looks at how diabetes and nerve damage affect your muscles and bones. It compares people with type 2 diabetes to healthy volunteers to learn more about these changes.
GhentAges 40–70 - NCT06520176RecruitingPhase 3
Comparing two stem cell collection methods for multiple myeloma
This study tests two different combinations of medicines to help collect stem cells for a transplant in people newly diagnosed with multiple myeloma. The goal is to see which approach works better and is safer for you.
Dongyang, ZhejiangAges 18–75 - NCT06520319RecruitingPhase 1
Comparing two PET tracers for recurrent MTC
This study compares a new imaging agent called 68Ga-MGS5 with the standard agent 68Ga-DOTATATE to see which one better detects recurrent medullary thyroid carcinoma on a PET/CT scan. The goal is to improve tumor detection in people whose MTC has returned.
Fuzhou, FujianAges 18–80 - NCT06520995Recruiting
Cognitive exercises for older adults with type 2 diabetes
This study tests whether doing special cognitive exercises at home can help older adults manage type 2 diabetes better. It is designed for people who are comfortable using a smartphone, tablet, or computer.
Istanbul, AvcılarAges 65 years+ - NCT06520839RecruitingPhase 3
Tadalafil for erectile dysfunction in diabetic men
This trial studies whether a drug called tadalafil can help men with diabetes who also have erectile dysfunction. It looks at how genetic factors might affect treatment response.
LjubljanaAges 40–65 - NCT06521086Recruiting
Better nutrition recovery for trauma patients
This study tests if a special nutrition plan helps older adults recover better after a traumatic injury. It aims to improve healing by providing extra nutrition through food and drinks.
Durham, North CarolinaAges 45 years+ - NCT06521541Recruiting
Prehabilitation program for stomach cancer surgery patients
This study tests a program of nutrition, exercise, and emotional support before and during chemotherapy and stomach cancer surgery. It aims to help patients recover faster and have fewer complications.
Qingdao, ShandongAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,836 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.